CD8A and breast cancer: Interestingly, Abx treatment led to a significant reduction of CD8+, but not CD4+ T cell subsets in the spleen or lung, and BC colonization restored the percentage of CD8+ T cells in these tissues (Figure 3(a) and Figure S3a).